NewsHealthTakeda's 40 years in Italy, 275 million investments over...

Takeda’s 40 years in Italy, 275 million investments over the next 5 years


“An increasing attention to the health of patients, their quality of life and to the issues of the environment, diversity, inclusion; an increasingly solid partnership with institutions, patient associations, researchers and doctors; a commitment ever stronger in terms of research, investment and employment “. It is with these promises that Takeda, a global biopharmaceutical company with headquarters in Japan, today celebrates 40 years of presence in Italy and looks to the future. It was 1982 when the company opened its Italian branch, the company recalls in a note, underlining that in these 4 decades it has “consolidated its presence in our country, making a significant contribution to the growth of the pharmaceutical sector and above all making a difference. in the life of patients “with R&D activities” in 4 main therapeutic areas – oncology, gastroenterology, neuroscience, rare diseases – to which are added targeted investments in the field of plasma-derived medicines and vaccines “.” Over the last 40 years Takeda in Italia has grown to become a reality of over 1,100 employees with two production sites in Rieti and Pisa, and a commercial office in Rome – declares Annarita Egidi, CEO of Takeda Italy – Since our foundation we have tried to put the needs of patients first. place in our activities, focusing on diseases that have the greatest need for new treatments, working to accelerate access to therapies And. In line with these objectives, from 2021 we have increased our investments in Research and Development globally by 10% and we have recently announced an investment plan of 275 million euros in Italy over the next 5 years, with the creation of 150 new jobs. “.” To offer better health to people and a brighter future for the world – adds Egidi – we have always relied on the values ​​of integrity, loyalty, honesty and perseverance that will continue to guide the work of our company and its role. strategic in the process of transformation of the National Health Service “. The company, concludes the note, consolidates its presence by continuing to invest in Italy with a renewed commitment to patients, the partnership with the National Health Service, inclusion and sustainability environmental.

Latest news

LIVE – For Louis Aliot, it is not Macron “who awards government patents” – BFMTV

11:02Only a little over a third of French people say they are "satisfied" with the action of Emmanuel MacronEmmanuel...

Covid, the study on the risks of neurodegenerative diseases

(Adnkronos) - The analysis conducted in Denmark

Mercato Mercato / Premier League: Cristiano Ronaldo (Manchester United), the improbable track… Chelsea – Eurosport FR

It's hard to imagine Cristiano Ronaldo playing in the Premier League in a shirt other than Manchester United. ...

VIDEO Richard Pánik won the Calder Cup in the AHL: Slovak helped Wolves in the fifth final – Š

Richard Pánik celebrates with teammates Source: SPRINGFIELD - Slovak hockey player Richard Pánik won the prestigious Calder Cup...

Teachers’ salaries: Pap Ndiaye promises 2,000 euros net per month for new teachers from 2023 – CNEWS

The Minister of National Education announced this Saturday that the salary of teachers who will start their career in...

You might also likeRELATED
Recommended to you